Clinical trials

Science is the foundation upon which we build our innovations, ensuring safety, efficacy and meaningful outcomes.

Product
ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)
Status

Recruiting – Click here for more information

Condition
Shoulder Osteoarthritis
Description

A Phase 3, Multicenter, Randomized, Double-Blind, Single-dose Study to Evaluate the Efficacy and Safety of ZILRETTA in Subjects with Glenohumeral Osteoarthritis

Program/Trial Name: REZILIENCE (006-C-301)
Phase: Phase 3
See Trial Details: NCT06269705

Product
EXPAREL® (bupivacaine liposome injectable suspension)
Status

Recruiting

Condition
Postoperative Analgesia
Description

A Multicenter, Open-label, Randomized, Bupivacaine -Controlled Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Aged 0 to Less Than 6 Years Undergoing Cardiac Surgery

Program/Trial Name: PLAY 0 - 6- Pediatric Local Infiltration (402-C-125)
Phase: Phase 1
See Trial Details: NCT06271265

Product
iovera°
Status

Recruiting – Click here for more information

Condition
Upper Extremity Spasticity
Description

A Multicenter, Randomized, Double-Blind, Sham-Controlled Study Assessing the Efficacy and Safety of iovera° System in Subjects with Upper Extremity Spasticity

Program/Trial Name: iovera° Spasticity (IOV-301)
Phase: Phase 3
See Trial Details: NCT06340451

Product
PCRX-201
Status

Active/not yet recruiting

Condition
Osteoarthritis of the Knee
Description

A Two-Part, Phase 2, Randomized, Double-blind, Active-Controlled Study to Assess the Safety and Tolerability of Enekinragene Inzadenovec (PCRX-201) in Subjects with Painful Osteoarthritis of the Knee

Program/Trial Name: 201-C-201
Phase: Phase 2
See Trial Details: TBD
Product
PCRX-201
Status

Active/not recruiting

Condition
Osteoarthritis of the Knee
Description

An Open-Label, Single Ascending Doe Study to Assess the Safety and Tolerability of FX201 in Patents with Osteoarthritis of the Knee

Program/Trial Name: FX201-2019-001
Phase: Phase 1
See Trial Details: NCT04119687

Product
Study type: Prospective Observational Patient Registry
Status

Recruiting

Condition
Osteoarthritis of the Knee
Description

Innovations in Genicular Outcomes Registry (IGOR) captures prospective observational data on patients receiving pain management for chronic pain due to knee osteoarthritis (OA) or pain optimization for knee arthroplasty due to knee OA. The OA pain therapies may include cryo nerve block, radiofrequency ablation (RFA), intra-articular (IA) corticosteroids, viscosupplementation, opioids, and others (e.g., non-steroidal anti-inflammatory drugs [NSAIDs]).

Program/Trial Name: IGOR: Innovations in Genicular Outcomes Registry (IOV-REG-001)
Condition: Osteoarthritis of the Knee (OAK)
Phase: N/A
See Trial Details: NCT05495334